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Abstract: In Switzerland, viruses belonging to two different phylogenetic 
groups of small ruminant lentiviruses (SRLV) are currently circulating: 
the caprine arthritis-encephalitis virus (CAEV) and visna/maedi virus 
(VMV). In the past two decades, a mandatory national control program has 
led to a very low prevalence of seropositivity, while completely 
eliminating CAE as a clinical manifestation. However, in order to reduce 
the high costs and effort associated with this program, adjustments based 
on the most recent epidemiological knowledge are needed. The purpose of 
this study was to estimate the seroprevalence of CAEV and VMV using the 
newest diagnostic tools available, and to identify potential risk factors 
for infection with these viruses in Switzerland. For the prevalence 
estimation, a census was carried out including 10,696 farms with a total 
of 85,454 goats. Blood samples were analysed using a 3-step serological 
testing algorithm consisting of Chekit ELISA, Western Blot and SU5 ELISA. 
A risk factor analysis was conducted using logistic regression models 
built with data obtained from a mail questionnaire, and serological 
results from the census. The apparent herd-level prevalences were 0.38%, 
2.77%, and 3.04% for CAEV, VMV and SRLV, respectively. Animal-level 
prevalences were 0.06% for CAEV, 0.55% for VMV, and 0.61% for SRLV. No 
statistically significant risk factors associated with CAEV or VMV 
infection were identified. However, the proportional high number of CAEV 
seropositive dwarf goats, in relation to their population size, could 
indicate that these hobby breeds may slip through some of the official 
controls. For an infection with SRLV, a medium herd size (7-40 goats) was 
found to be protective, compared with smaller (OR=1.90, p=0.034) and 
larger herds (OR=1.95, p=0.038). In conclusion, considering that all CAEV 
positive animals were culled, these results imply that CAEV is no longer 
actively spreading and has successfully been controlled in Switzerland. 
However, given the uncertain pathogenic potential of VMV in goats, future 
surveillance should also be taking into account the not insignificant 
number of VMV circulating in the Swiss goat population. 
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Revision Note: 
 
Dear Reviewer, 
 
Thank you for your valuable comments on the analyses of dwarf goat farms. This helped us to identify a 
mistake (comparison of farm sizes of dwarf and “non-dwarf goat” farms) that led to a potential 
misunderstanding of the entire section. We corrected this mistake and also adjusted the methods and 
results section, which should have improved overall comprehension and clarity. 
 
Reviewer #2: this is much improved although the English is a bit poor in places. 
 
One concern I still have is that the authors are still focusing in on 7 seropositive dwarf goats for which 
they have done further analysis without presenting initial population data. These results are done as a 
proportion of positive goats ie not using a population denominator and they then analyse farms with 
dwarf goats as a proportion of positive farms and report that these farms were smaller than other CAEV 
positive farms etc but the analysis is not described in the methods and I cannot see these descriptive 
data or what was tested to develop the final model. These analyses are based on data from 32 farms 
(line 215) , and  contrast to their logistic model where other variables were significant or near significant 
at p 0.05, it raises the question of how this model was built and which tested e.g. purchase of female 
goats.  
 
Only the descriptive statistics of the CAEV seropositive goats (former Table 5, now Table 4) is based on 
the responses (n=34) of the additional questions on individual goats (as described in lines 130-133). All 
analyses for dwarf goat farms were conducted on a farm level with the same, full dataset that was used 
for the CAEV risk factor logistic modeling (n=163). 
 
Thanks to the reviewer’s comments, we identified a mistake in the manuscript: Dwarf goat farms (n=24, 
independent of CAEV status) were not smaller than other CAEV positive farms (as stated in the previous 
version of the manuscript: “Dwarf goat farms were smaller (p<0.001) than other CAEV positive farms.” 
[Revision 1, lines 219-220]), but they were smaller than “non-dwarf goat” farms (n= 139, independent of 
CAEV status). Thank you for pointing this out! We understand that this mistake has led to confusion on 
the whole sections of dwarf goat analyses and have corrected and rewritten this paragraph: 
 
“Of the 47 CAEV seropositive goats detected during the census, detailed data on 34 goats located on 32 
farms were reported through the questionnaire and available for descriptive statistics (Table 4). Seven of 
the 34 (20.6%) CAEV positive goats were dwarf goats, whose overall population size (Zwergziegen-IG, 
2016) is substantially smaller compared with the population of the main goat breeds in Switzerland, such 
as Chamois colored or Saanen (SZZV, 2016). Dwarf goat farms (n=24) were smaller (median=8, p<0.001) 
than “non-dwarf goat” farms (n=139, median=16). Furthermore, fewer (66.7%, p=0.002) dwarf goat 
owners were professional farmers, compared to owners of other goat breeds (90.0%). Only 37.5% (n=9) 
of the dwarf goat farms had been tested for SRLV before 2012, compared to 56.8% (n=79, p=0.079) of the 
farms without dwarf goats.” [lines 217-226] 
 
Given that variables such as not tested before 2012 is not significant in the full model and is also 0.08 
significance in the model of 32 farms, small farms are more likely to have dwarf goats but these are 
protective for SRLV positivity (Table 3 supplementary material) what does ia proportional risk model 
mean? after all these are all positive farms. I still believe there is insufficient logic to present this section 
of results. 
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As stated above statistics on dwarf goat farms were not conducted with the 32 CAEV positive farms only, 
but the same dataset as for the CAEV risk factor analysis (n=163). In the “full model” as the reviewer 
refers to, “tested before 2012” was checked for an association with CAEV seropositive farm status. In the 
“additional statistical analyses” the association between “dwarf goat farm” and “tested before 2012” 
was investigated, but with the same dataset. This methodology was not described in the methods 
section, and has now been added: 
 
“For the additional statistical analyses on dwarf goat farms, the same data set as for the CAEV risk factor 
analysis was used. Farm size comparisons are based on differences in medians (Wilcoxon rank-sum test), 
whereas a chi-square test was used to analyse educational level of the farmers and testing for SRLV 
before 2012.” [lines 158-161] 
 
Thank you a lot for pointing this out! 
 
Former Supplementary Table III (now Table 3) does not indicate that small farms are protective for SRLV 
positivity. (OR: 1.90, p=0.034). 
 
We believe that by correcting the mistake mentioned above and by adjusting the methods [lines 158-161] 
and results section [lines 216-226], the additional analyses conducted with dwarf goat farms should now 
be clear, correct and justified. 
 
tables are muddled and need some reflection – 
Table 1 is fine but needs number of herds and animals testd in the title Table 2 and 3, why put these in 
the main text and not supplementary table 3 which is the model for these data Table 4, need number of 
herds and case control in title under cases and control this is presumably number, given there are many 
more controls than cases a % is needed to compare the relative proportions Table 5 - is this the data 
used ot build the model in 3.2.2 why are other variables not used? is the model appropriate etc 
 
 The title of Table 1 has been reworded: 
“Herd-level (n=10,696) and animal-level (n=85,454) seroprevalences (95% CI) for CAEV, VMV and 
SRLV.” 
 
 Tables 2 and 3 have been moved to the supplementary material (now Supplementary Table I and II). 
Former Table 3 (now Supp. Table II) shows only descriptive statistics of continuous variables. The data 
used were from all questionnaire responses (n=341), as described in line 194-196. 
 
 Table 4 (now Table 2) was adjusted according to the suggestions, the title has been updated and 
proportions (%) were added to the table: 
“Univariable analysis of variables tested for their association with CAEV seropositivity in case (n=32) 
and control (n=131) herds.” 
 
 Table 5 (now Table 4): 
This data was not used for any modeling but for characterization purposes only. All logistic regression 
analyses are based on herd-level data, including the analyses for farms that hold dwarf goats. 
 
supp Table 1 needs number of herds etc, i am not sure this table is needed at all supp Table II again 
needs numbers time periods etc in title i question if supp III should be in the main text 
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Thank you for these suggestions. The tables have been adjusted accordingly. 
 Supplementary Table 1 has been removed from the manuscript. 
 
 The title of Supplementary Table II (now Supp. Table III) has been reworded and proportions (%) have 
been added to the table: 
“Univariable analysis of variables tested for their association with VMV seropositivity in case (n=100) 
and control (n=131) herds.” 
 
 Supplementary Table III has been moved to the main text (now Table 3). 
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Abstract 1 
In Switzerland, viruses belonging to two different phylogenetic groups of small ruminant 2 
lentiviruses (SRLV) are currently circulating: the caprine arthritis-encephalitis virus (CAEV) 3 
and visna/maedi virus (VMV). In the past two decades, a mandatory national control program 4 
has led to a very low prevalence of seropositivity, while completely eliminating CAE as a 5 
clinical manifestation. However, in order to reduce the high costs and effort associated with 6 
this program, adjustments based on the most recent epidemiological knowledge are needed. 7 
The purpose of this study was to estimate the seroprevalence of CAEV and VMV using the 8 
newest diagnostic tools available, and to identify potential risk factors for infection with these 9 
viruses in Switzerland. For the prevalence estimation, a census was carried out including 10 
10,696 farms with a total of 85,454 goats. Blood samples were analysed using a 3-step 11 
serological testing algorithm consisting of Chekit ELISA, Western Blot and SU5 ELISA. A 12 
risk factor analysis was conducted using logistic regression models built with data obtained 13 
from a mail questionnaire, and serological results from the census. The apparent herd-level 14 
prevalences were 0.38%, 2.77%, and 3.04% for CAEV, VMV and SRLV, respectively. 15 
Animal-level prevalences were 0.06% for CAEV, 0.55% for VMV, and 0.61% for SRLV. No 16 
statistically significant risk factors associated with CAEV or VMV infection were identified. 17 
However, the proportional high number of CAEV seropositive dwarf goats, in relation to their 18 
population size, could indicate that these hobby breeds may slip through some of the official 19 
controls. For an infection with SRLV, a medium herd size (7-40 goats) was found to be 20 
protective, compared with smaller (OR=1.90, p=0.034) and larger herds (OR=1.95, p=0.038). 21 
In conclusion, considering that all CAEV positive animals were culled, these results imply 22 
that CAEV is no longer actively spreading and has successfully been controlled in 23 
Switzerland. However, given the uncertain pathogenic potential of VMV in goats, future 24 
*Manuscript
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surveillance should also be taking into account the not insignificant number of VMV 25 
circulating in the Swiss goat population. 26 
Keywords 27 
Small ruminant lentivirus; Caprine Arthritis-Encephalitis Virus; Visna/maedi Virus; 28 
Prevalence; Risk Factor; Census  29 
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1. Introduction 30 
Caprine Arthritis-Encephalitis (CAE) is a widespread goat disease caused by the CAE-31 
Virus (CAEV), a Lentivirus within the family of Retroviridae. Another virus of the same 32 
genus is the Visna/Maedi Virus (VMV), which is responsible for the Visna-Maedi (VM) 33 
disease in sheep. Together, CAEV and VMV form the group of Small Ruminant Lentiviruses 34 
(SRLV). Small Ruminant Lentiviruses, depending on the genotype, may cause chronic 35 
inflammatory and degenerative lesions in the joints, mammary glands, lungs and brain of 36 
goats and sheep (Dawson, 1987; Narayan and Clements, 1989). Of the different SRLV 37 
genotypes, B1 is considered as the prototype for CAEV, whereas genotype A1 is the 38 
prototype for VMV. While B1 was the principal genotype circulating in Swiss goat herds 39 
before the eradication campaign, it seems that, at present, VMV A4 is the dominating SRLV 40 
genotype (Cardinaux et al., 2013). From now on, the terms CAEV and VMV will be used to 41 
refer to either genotypes B or genotypes A, respectively, to allow for better readability of the 42 
manuscript. 43 
In Switzerland, a voluntary eradication program for CAE in goats was launched in 1984, 44 
when seroprevalence in the Swiss goat population was around 60-80% (Peterhans et al., 45 
2004). In 1998, eradication of CAE became mandatory, and in the same year the last 46 
confirmed clinical CAE case in Switzerland was reported. From 2006 until 2011, the Swiss 47 
Federal Food Safety and Veterinary Office (FSVO) reported prevalences of 0.77% to 10.28% 48 
(FSVO 2006 – 2011), based on an annual sampling of 25% of all goat farms. However, 49 
previous diagnostic tests could not distinguish between CAEV and VMV (Zanoni, 1998), and 50 
estimates published before 2012 therefore refer to infections with all SRLV, including goats 51 
seropositive for VMV. Following the introduction of an additional diagnostic test which 52 
permitted to distinguish between the two genotypes, in 2012 the Swiss federal authorities 53 
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decided to conduct a census and restrict the eradication campaign to the CAEV genotypes 54 
only. 55 
Despite previous achievements and the ongoing eradication program, seroconversions, 56 
mainly related to VMV, continue to occur in Switzerland. To reduce further transmission of 57 
these viruses, it is important to understand which factors are associated with CAEV and VMV 58 
infections in goats. The main routes of transmission of SRLV are either vertically, through 59 
ingestion of infected colostrum or milk, or horizontally through inhalation of respiratory 60 
secretions, though intra-uterine infection can also occur (Blacklaws et al., 2004). In addition, 61 
natural cross species transmission in mixed flocks from goat to sheep, and vice versa, has also 62 
been described (Germain et al., 2008; Leroux et al., 1997; Pisoni et al., 2005; Shah et al., 63 
2004). Potential risk factors described in the literature include close contact to SRLV 64 
seropositive sheep, the import of goats from abroad, the presence of seropositive bucks in a 65 
herd, as well as large herds (Brülisauer et al., 2005; Kaba et al., 2013). As mentioned 66 
previously however, diagnostic tools available at the time when these studies were conducted 67 
could not distinguish between CAEV and VMV infections, and their results often refer to 68 
SRLV in general. Given the advent of new diagnostic tools, a risk factor analysis for the 69 
separate genotypes could shed light on specific differences between the viruses. 70 
The objectives of this study were to use the census data based on the new diagnostic test 71 
to (i) provide for the first time SRLV prevalence estimates in the Swiss goat population, 72 
discriminating between CAEV and VMV, and (ii) determine risk factors associated with 73 
CAEV and VMV infection in goats. Results from this study will permit the veterinary 74 
authorities to make evidence based decisions on future surveillance and control of this 75 
disease, thus optimizing resource allocation. 76 
  77 
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2. Materials and methods 78 
2.1 Prevalence estimation 79 
2.1.1 Census and laboratory analysis 80 
As part of the national CAE control program, a census of all goat herds registered in 81 
Switzerland was conducted and coordinated by the FSVO. Goat herds were visited and 82 
sampled by veterinarians between October 2011 and August 2012. The sampling unit was the 83 
single animal and blood samples (5-10ml whole blood) were taken from all goats that were 84 
six months of age or older. The diagnostic procedure consisted of different serological 85 
methods forming a 3-step serial testing algorithm (Figure 1). All blood samples were initially 86 
screened using Chekit CAEV/VMV Total Antibody Screening ELISA Test (Idexx 87 
Switzerland AG, Liebefeld, Switzerland) by one of the ten accredited regional laboratories. 88 
Positive and indeterminate sera were then sent to the National Reference Laboratory at the 89 
Institute of Veterinary Virology, University of Bern, where the same ELISA test was 90 
repeated. If the ELISA positive result was confirmed, a Western Blot (WB) was performed, 91 
and WB positive sera were then analysed using a panel of surface subunit (SU) 5 peptides 92 
derived from different SRLV genotypes (Bertoni et al., 2014; Mordasini et al., 2006). This 93 
SU5 ELISA analysis permitted to distinguish between CAEV and VMV positive sera; 94 
undifferentiated sera were classified as “CAEV positive by default”. 95 
2.1.2 Statistical analysis 96 
The estimation of herd- and animal-level prevalences was based on the census data 97 
and the confirmed seropositive results from the National Reference Laboratory. A herd was 98 
considered CAEV or VMV seropositive if at least one goat had a corresponding SU5 ELISA 99 
positive test result. All apparent prevalences (AP) were then converted into true prevalence 100 
(TP) estimates by means of the Rogan and Gladen estimator (1978). In order to visualize 101 
seropositive cases, a map with the spatial distribution of positive farms was designed using 102 
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ArcGIS 10 (ESRI, 2010). Case farms were located based on their postal code. Information 103 
about the density of small ruminants at the municipality level (FSVO) was mapped as a 104 
background layer. 105 
2.2 Risk factor analysis 106 
2.2.1 Study design and study population 107 
A case-control study was conducted to determine risk factors associated with a CAEV and 108 
VMV positive farm status. For the cases, all farms that tested positive in the census were 109 
selected and three groups of cases were defined: (i) CAEV, (ii) VMV and (iii) SRLV. CAEV 110 
cases were defined as farms that tested CAEV seropositive in the SU5 ELISA. All farms that 111 
tested VMV positive, but without CAEV and “CAEV positive by default” results, were 112 
treated as VMV cases. Finally, SRLV cases were all those farms that had at least either one 113 
CAEV or VMV but had no “CAEV positive by default” test result. Controls were selected 114 
randomly from farms that tested negative in the census and had no history of SRLV 115 
seropositivity in the previous five years (2006 until 2011). Since only 41 farms were tested 116 
positive for CAEV and 284 farms positive for VMV, all these farms were included in our 117 
study. The number of control farms required was estimated using a logistic regression power 118 
analysis conducted in PASS12 (Hintze, 2013), to detect an odds ratio (OR) for risk factors 119 
greater than 2, with a power of 80% (α = 5%). Based on these calculations, a minimum of 120 120 
controls was necessary. 121 
2.2.2 Questionnaire 122 
Epidemiological data from each case and control farm were collected through a standardized 123 
mail questionnaire. As the questionnaire was distributed to farmers in December 2013 none of 124 
the farms that tested positive in the 2012 CAE census were still under animal movement 125 
restrictions at the time the data were collected. The questionnaire consisted of 33 questions 126 
grouped into the following 5 categories: (i) farm type, breeds and number of animals; (ii) 127 
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farming know-how and education; (iii) contact with goats from other farms through trade, 128 
breeding, shows or common pasture; (iv) contact with own or foreign sheep through common 129 
pasture; (v) farm status for CAEV infection in the previous five years. Farmers with CAEV 130 
positive goats were also asked to provide specific information on each CAEV positive goat. 131 
These additional seven questions, which aimed to gather information on the age, sex, breed, 132 
origin, place of purchase and contact with sheep, were used for descriptive purposes only. The 133 
questionnaire was pre-tested on goat owners to ensure clarity of the questions. To reduce bias 134 
due to possible changes in management practices or increased disease awareness following 135 
the census results, and to account for the time lag between when the census and the survey 136 
were conducted, questions on animal movement or contact were phrased as “mean over the 137 
past two years”, “on average”, “normally” or “temporarily”. The questionnaire was 138 
distributed in German, French or Italian language and is available from the corresponding 139 
author upon request. 140 
2.2.3 Statistical analyses 141 
The questionnaire data were transferred into an Excel spreadsheet (Microsoft Excel 142 
2010) and analysed using STATA 13 (StataCorp., 2013). Predictor variables were checked for 143 
missing values and possible errors in data transcription, and continuous variables were also 144 
checked for linearity and restructured if needed. 145 
To identify possible risk factors, the three case groups, (i) CAEV, (ii) VMV, and (iii) 146 
SRLV, were defined as binary outcomes (positive or negative) in the model-building process. 147 
For each of the three independent models, the corresponding data set was used and 148 
univariable associations between the putative risk factors as independent variables and the 149 
serological status were tested using logistic regression. Univariable ORs and p values were 150 
calculated and ranked. Independent variables that were significantly associated with outcomes 151 
at a liberal p value of <0.20 were assessed for co-linearity (Pearson correlation coefficient 152 
8 
 
>0.8) and defined as candidate risk factors. The multivariable logistic regression models were 153 
built using a stepwise backward elimination procedure, initially including all candidate risk 154 
factor as independent variables. Based on likelihood-ratio tests, candidate risk factors that 155 
were significant (p<0.05) were retained in the final model and were tested for two-way 156 
interactions (p<0.05). The goodness-of-fit of the final models were tested using the Hosmer-157 
Lemeshow test. For the additional statistical analyses on dwarf goat farms, the same data set 158 
as for the CAEV risk factor analysis was used. Farm size comparisons are based on 159 
differences in medians (Wilcoxon rank-sum test), whereas a chi-square test was used to 160 
analyse educational level of the farmers and testing for SRLV before 2012.  161 
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3. Results 162 
3.1 Seroprevalence and spatial distribution 163 
Within the framework of the census, 85,454 individual goats located on 10,696 164 
different farms were tested. A total of 729 animals from 452 farms were classified as WB 165 
positive, of which 47 (6.4%) animals were further classified as CAEV infected and 473 166 
(64.9%) as VMV infected by means of the SU5 ELISA. The remaining 209 (28.7%) WB 167 
positive sera were classified as “CAEV positive by default” as they could not be further 168 
described using this panel of SU5 peptides; these were therefore excluded from further 169 
prevalence estimation. However, for the purposes of the national eradication program, these 170 
animals were considered as potentially CAEV infected and were therefore culled. 171 
The 47 CAEV positive goats were located on 41 farms. Of these farms, 36 (87.8%) 172 
had 1 positive goat each, 4 farms had 2 positive goats, and 1 farm had 3 positive goats; the 173 
median within-herd prevalence was 5.9% (min=0.5%, max=66.7%). The 473 VMV infected 174 
goats were located on 296 farms. The majority of these farms (78.7%) had only one VMV 175 
seropositive goat. Twelve farms (4%) had both CAEV and VMV positive goats, resulting in a 176 
total of 325 SRLV positive farms. Consequently, the AP at a herd level were 0.38%, 2.77%, 177 
and 3.04% for CAEV, VMV and SRLV, respectively, while the TP estimates were 0.40%, 178 
32.21% and 32.27%. The animal-level AP were 0.06%, 0.55% and 0.61%, while TP estimates 179 
were 0.06%, 6.40% and 6.46% for CAEV, VMV and SRLV, respectively. All prevalence 180 
estimates are listed in Table 1. 181 
The 41 CAEV positive farms were evenly distributed over the whole territory of 182 
Switzerland and no regional patterns could be observed (Figure 2). Similarly, the VMV 183 
positive farms were detected all over Switzerland; however, regional patterns in accordance 184 
with the regional differences in animal density and topography, were noticeable for these 185 
farms. 186 
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3.2 Risk factor analysis 187 
3.2.1 Study population and response rate 188 
Based on the diagnostic test results, questionnaires were administered to all 452 farms 189 
that tested positive with the WB, including the 127 “CAEV positive by default” farms. 190 
However, the latter were only considered for descriptive purposes and later excluded from the 191 
risk factor analysis. Overall, 752 questionnaires (including 300 for control farms) were sent 192 
out, of which 13 could not be delivered. Of the 739 delivered questionnaires, 396 were 193 
completed and returned, resulting in an overall response rate of 54%. Of these, 55 farms had 194 
to be omitted either because the farm identification was missing (n=37) or because they no 195 
longer kept goats (n=18). The response rate for CAEV positive farms was 78% (32 of 41). 196 
Finally, a full data set was available for 341 farms. Descriptive statistics of the categorical and 197 
continuous variables of these farms are presented in Supplementary Table I and 198 
Supplementary Table II, respectively. 199 
3.2.2 Logistic regression 200 
Based on the case definition, the risk factor analysis was conducted on 32 CAEV, 100 201 
VMV and 125 SRLV case farms. A total of 131 controls were used for the risk factor 202 
analysis. The univariable analysis identified “purchase of female goats” (p=0.093, OR=2.17) 203 
as the only predictor variable marginally associated (p<0.10) with a positive CAEV status, 204 
while the association between dwarf goat ownership and CAEV positive status was just above 205 
the threshold value (p=0.208, OR=1.88). Thus, no multivariable model for CAEV could be 206 
built. Results of the univariable analysis for other variables considered relevant are presented 207 
in Table 2. The final multivariable model for VMV did not identify any significant risk 208 
factors either. Nevertheless, four variables were marginally significant in the univariable 209 
analysis: “herd size” (small vs. medium herds, OR=1.82; large vs. medium herds, OR=1.89) 210 
and “Appenzell breed” (OR=3.21) as candidate risk factors, while “know-how” (OR=0.53) 211 
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and “breeding done with own buck” (OR=0.62) as putative protective factors for VMV in 212 
goats (Supplementary Table III). For an infection with SRLV, the final model included the 213 
following two variables: “Appenzell breed” (OR=4.10) and “herd size” (small vs. medium 214 
herds, OR=1.90; large vs medium herds, OR=1.95) (Table 3). 215 
3.3 Additional statistical analyses 216 
Of the 47 CAEV seropositive goats detected during the census, detailed data on 34 goats 217 
located on 32 farms were reported through the questionnaire and available for descriptive 218 
statistics (Table 4). Seven of the 34 (20.6%) CAEV positive goats were dwarf goats, whose 219 
overall population size (Zwergziegen-IG, 2016) is substantially smaller compared with the 220 
population of the main goat breeds in Switzerland, such as Chamois colored or Saanen 221 
(SZZV, 2016). Dwarf goat farms (n=24) were smaller (median=8, p<0.001) than “non-dwarf 222 
goat” farms (n=139, median=16). Furthermore, fewer (66.7%, p=0.002) dwarf goat owners 223 
were professional farmers, compared to owners of other goat breeds (90.0%). Only 37.5% 224 
(n=9) of the dwarf goat farms had been tested for SRLV before 2012, compared to 56.8% 225 
(n=79, p=0.079) of the farms without dwarf goats.  226 
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4. Discussion 227 
This is the first study in Switzerland where, by means of newly applied diagnostic 228 
tools, SRLV infected goats could be further classified as CAEV (genotypes B) and VMV 229 
(genotypes A) infected. This, in turn, allowed for genotype specific prevalence estimations 230 
and risk factor analyses. In addition, the prevalence estimations published in this study are 231 
based on a census, compared to earlier Swiss publications. 232 
Only 47 CAEV positive goats (TP animal-level 0.06%), located on 41 farms (TP herd-233 
level 0.40%) were detected, indicating that the eradication campaign is progressing 234 
successfully. A comparison with previous publications should be done with caution as, due to 235 
the lack of discriminatory tests for the different genotypes until recently, as they refer to a 236 
global SRLV seroprevalence. Furthermore, different studies reported either AP or TP, and 237 
should therefore not be compared directly. The herd-level AP for SRLV described in this 238 
study (3.04%) differs from previous estimates for Switzerland (0.77% - 10.28%, FSVO 2006 239 
- 2011); it is higher compared to that reported for 2006 and 2007, but lower than that reported 240 
between 2008 and 2011. However, the estimates in 2008 and 2009 could have increased due 241 
to the ongoing bluetongue vaccination campaign (FSVO, 2009, 2010), which might have 242 
generated false positive results in the Screening ELISA Test (Valas et al., 2011). For the years 243 
2010 and 2011, the reported estimates are considered as not representative as either the 244 
sample sizes were too small or the samples were not taken randomly (FSVO, 2011, 2012). 245 
The large difference between SRLV AP and TP estimates in this study is driven by the poor 246 
sensitivity of the Screening ELISA for VMV genotypes, which comprise the vast majority 247 
(91%) of SRLV seropositive goats detected during the census, and resulted a combined 248 
overall sensitivity of 8.6% (Cardinaux et al., 2013). Since the SRLV positive results could not 249 
be subdivided into CAEV or VMV prior to the 2012 census, it remains unclear how much of 250 
the previous SRLV estimates were due to VMV cases. VMV seropositive goats are currently 251 
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excluded from mandatory culling as VMV infection in goats is still considered as non-252 
pathogenic (despite recent histological evidence by Deubelbeiss et al., (2014) that VMV could 253 
cause mastitis) and VMV prevalence may thus rise in the coming years. Considering the fact 254 
that all goats that tested CAEV positive were culled, it might be assumed that VMV 255 
prevalence (TP herd-level: 32.21%, TP animal-level: 6.40%) currently equals SRLV 256 
prevalence. 257 
A considerable number of WB positive animals escaping SU5 ELISA classification 258 
(28.7%) were reported by the National Reference Laboratory as “CAEV positive by default” 259 
and therefore culled. This decision was taken to reduce the risk that infected animals with 260 
false negative SU5 ELISA results may jeopardize the success of the eradication campaign. 261 
Previous work has shown that the sensitivity of the SU5 ELISA test is excellent with well 262 
characterized viruses but may fail with variant strains, leading to possible false negative cases 263 
(Bertoni et al., 2014). 264 
During the 2012 census, numerous farms were tested for SRLV for the first time, and 265 
several of these were hobby farms that were not previously registered. It is plausible that 266 
dwarf goats are held on such farms, with potentially less professional management practices. 267 
Even though, before the 2012 census, the dwarf goat farms were not tested significantly less 268 
frequently compared with other farms (p=0.079), a trend is identifiable. This might be a 269 
possible explanation for the proportionally high number of CAEV seropositive dwarf goats 270 
detected. 271 
Since only few publications distinguish between CAEV and VMV, knowledge on the 272 
transmission routes for each genotype is limited. Vertical transmission through colostrum and 273 
milk appears to be the main infection route for CAEV-infected goats. The situation in sheep 274 
appears to be more complex, with horizontal transmission of SRLV playing a more important 275 
role (Alvarez et al., 2005; Bertoni et al., 2014; Peterhans et al., 2004). This indicates that 276 
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alternative control measures might be necessary when aiming to control SRLV in sheep 277 
populations. In CAEV and VMV co-infected goats, there is evidence that VMV is more 278 
efficiently transmitted to the suckling kids, suggesting a rapid spread of VMV in goat 279 
populations (Pisoni et al., 2010). Further research is needed to understand how efficiently 280 
CAEV is transmitted horizontally, both within goat herds, as well as between goats and sheep. 281 
A low horizontal transmission rate of CAEV could explain the presence of only a single 282 
seropositive goat in each CAEV case farm, as well as the even and almost random distribution 283 
of CAEV cases over the country. Even if some CAEV positive goats have escaped detection 284 
due to imperfect diagnostic tests, we expect a very slow spread of the virus in the future 285 
(unpublished data). In contrast, the regional patterns observed with VMV cases are suggestive 286 
of a more efficient horizontal transmission of these viruses. 287 
No significant risk factors for an infection with CAEV could be determined in this 288 
study, which differs from other publications (Brülisauer et al., 2005; Kaba et al., 2013), 289 
though the univariable regressions identified an association between CAEV positive status 290 
and “purchase of female goats”, similar to previous findings by Brülisauer et al. (2005). 291 
However, as mentioned before, past studies refer to risk factors for an infection with SRLV 292 
and not only with CAEV. Additionally, a major limitation in our risk factor analysis was the 293 
small number of CAEV case farms (n=32) included (despite the high response rate). 294 
Ironically, this fact can be seen as a negative “side effect” of the success of the eradication 295 
campaign over the last two decades, which has led to a low prevalence. Furthermore, the 296 
retrospective study design might have introduced bias due to potential improved disease 297 
awareness and consequent changes in management practices following the census results. 298 
Although no risk factors for an infection with VMV were determined, the univariable 299 
analysis identified seven variables below the threshold point (p<0.20). This difference in 300 
number of putative risk factors, compared to the CAEV analysis, may be attributed to the 301 
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higher number of VMV case farms (n=100) included in the analysis. SRLV risk factors 302 
obtained from the present case-control study, similar to the SRLV prevalence, were strongly 303 
influenced by the large proportion of VMV case farms. The observed higher odds (OR=1.90) 304 
of SRLV seropositivity in small herds, compared to medium sized herds, could be explained 305 
by less professional management practices often observed on such smaller farms. On the other 306 
hand, large herds could be at a higher odds (OR=1.95) of infection due to greater animal 307 
movements which may favor disease transmission (Kaba et al., 2013). Goats from the 308 
Appenzell breed were found to be a significant risk factor for SRLV (OR=4.10), and this 309 
tendency was also observed with VMV positive status. However, only a small number of 310 
participating farms (n=12) held goats from the Appenzell breed.  311 
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Conclusion 312 
While the disappearance of clinical cases of CAEV-induced arthritis in Switzerland 313 
suggested that the eradication campaign had succeeded in eliminating virulent CAEV strains 314 
from the goat population, this study, based on a detailed epidemiological analysis of a 315 
serological survey involving the entire goat population, further confirms and expands this 316 
observation. Therefore we believe that classical CAEV genotypes are no longer circulating 317 
between goats in Switzerland, permitting us to conclude that these viruses may be considered 318 
as eradicated. In contrast, it seems that VMV genotypes may be actively transmitted in goat 319 
herds, pointing to the importance of regularly monitoring these infections, particularly since 320 
their pathogenic potential is still uncertain. In this respect, we are currently developing 321 
epidemiological models that will permit to perform this monitoring in a targeted and 322 
economically efficient way. 323 
  324 
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Figure 1 1 
3-step serological testing algorithm used to determine SRLV status with corresponding test 2 
sensitivities/specificities (%) for CAEV and VMV. 3 
1
CAEV: 97.9/98.1; VMV: 43.0/100 4 
2
CAEV: 98.0/95.0; VMV: 35.0/100 5 
3
CAEV: 99.0/99.0; VMV: 57.0/50.0 6 
 7 
Figure 2 8 
Spatial distribution of CAEV (n=41) and VMV (n=284) seropositive farms. 9 
Figure Captions
Table 1 1 
Herd-level (n=10,696) and animal-level (n=85,454) seroprevalences (95% CI) for CAEV, 2 
VMV and SRLV. 3 
 
CAEV 
(genotypes B) 
VMV 
(genotypes A) 
SRLV 
(genotypes A and B) 
    
Herd-level 
   
Number of seropositive herds 41 296 325
a
 
Apparent seroprevalence 0.38% 2.77% 3.04% 
True seroprevalence 0.40% 32.21% 32.27% 
 (0.34-0.46) (31.92-32.50) (31.97-32.57) 
Animal-level 
   Number of seropositive animals 47 473 520 
Apparent seroprevalence 0.06% 0.55% 0.61% 
True animal seroprevalence 0.06% 6.40% 6.46% 
 (0.06-0.07) (6.35-6.44) (6.41-6.51) 
a 
12 farms with both CAEV and VMV positive animals. 4 
Table1
Table 2 1 
Univariable analysis of variables tested for their association with CAEV seropositivity in case (n=32) and control (n=131) herds. 2 
Variable Description 
Cases  Controls 
p value Odds Ratio 
Odds Ratio 
(95% CI) n %  n % 
    
 
     
Animal show 
Goats taken to breed shows or goat markets at least every other 
year 
10 31.3  41 31.3 0.996 1.00 0.43-2.30 
Breeding Breeding of animals done on farm 27 84.4  116 88.5 0.520 0.70 0.23-2.09 
Breed Appenzell Appenzell breed present in herd 2 6.3  3 2.3 0.264 2.84 0.45-17.78 
Breed dwarf goat Dwarf goat breed present in herd 7 21.9  17 13.0 0.208 1.88 0.70-5.01 
Contact alpine Common alpine pasture with foreign goats/sheep 10 31.3  37 28.2 0.737 1.15 0.50-2.67 
Contact sheep Keep goats and sheep together with direct contact 7 21.9  21 16.0 0.434 1.47 0.56-3.83 
Herd size 
  
  
 
 0.642 
  
 
Medium herd (7-40 goats) 15 46.9  71 54.2 (ref) 1.00 - 
 
Small herd (1-6 goats) 8 25.0  33 25.2 0.777 1.15 0.44-2.97 
 
Large herd (>40 goats) 9 28.1  27 20.6 0.341 1.58 0.62-4.03 
Know-how 
Know-how based on agricultural education and/or membership 
in a goat association 
27 84.4  114 87.0 0.695 0.81 0.27-2.38 
Own buck Breeding done with own buck(s) 22 68.8  87 66.4 0.801 1.11 0.48-2.55 
Purchase Purchase of at least one goat per year 15 46.9  59 45.0 0.852 1.08 0.50-2.34 
Purchase female Purchase of at least one female goat per year 9 28.1  20 15.3 0.093 2.17 0.88-5.37 
Tested before 2012 Farm tested for SRLV before the 2012 census (2006-2011) 16 50.0  72 55.0 0.614 0.82 0.38-1.78 
Wildlife 
  
  
 
 0.403 
  
 
No observed contact with wildlife 24 75.0  98 74.8 (ref) 1.00 - 
 
Observed contact with ibex 3 9.4  5 3.8 0.241 2.45 0.55-10.97 
 
Observed contact with chamois and other Swiss wildlife 5 15.6  28 21.4 0.556 0.73 0.25-2.09 
 3 
Table2
Table 3 1 
Final multivariable logistic regression model of risk factors associated with small ruminant 2 
lentiviruses (SRLV) infection in goats. 3 
Variable Description se p value Odds Ratio Odds Ratio 
(95% CI) 
      
Breed Appenzell Appenzell breed present in herd 2.83 0.041 4.10 1.06-15.84 
Herd size 
  
0.039 
  
 
Medium herd (7-40 goats) 
 
(ref) 1.00 - 
 
Small herd (1-6 goats) 0.57 0.034 1.90 1.05-3.43 
 
Large herd (>40 goats) 0.63 0.038 1.95 1.04-3.66 
 4 
Table3
Table 4 1 
Characterization of individual goats (n=34) that tested CAEV seropositive during the 2012 2 
census. 3 
Variable Categories n % 
Sex Female 28 82 
 Male 6 18 
    
Origin Own breeding 20 59 
 Bought in 14 41 
    
Place of purchase (n=14) Private 14 100 
 Market 0 0 
    
Contact with sheep (n=33) Yes 8 24 
 No 20 61 
 Not known 5 15 
    
Breed Dwarf goat 7 20 
 Mixed breed 7 20 
 Saanen 6 18 
 Chamois colored 4 12 
 Grisons striped 3 9 
 Peacock goat 3 9 
 Buren 2 6 
 Valais Blackneck 1 3 
 Nera Verzasca 1 3 
 4 
Table4
Supplementary Table I 1 
Descriptive statistics of categorical variables in a study to determine risk factors for SRLV 2 
seropositivity (n=341). 3 
Variable Description Categories n % 
     
Alpine pasture Goats taken on alpine pasture in the summer Yes 134 39 
 No 207 61 
     
Animal show Goats taken to breed shows or goat markets at 
least every other year 
Yes 112 33 
 No 229 67 
     
Breeding Breeding of animals done on farm Yes 290 85 
 No 51 15 
     
Contact alpine Common alpine pasture with foreign 
goats/sheep 
Yes 106 31 
 No 235 69 
     
Contact sheep Keep goats and sheep together with direct 
contact 
Yes 64 19 
 No 277 81 
     
Contact wildlife Observed contact (<5meters) with wildlife 
animals  
Yes 89 26 
 No 252 74 
     
Farm type Goat farm production type Milk 131 38 
 Other 210 62 
     
Know-how Know-how based on agriculture education 
and/or goat association membership 
Yes 281 82 
 No 60 18 
     
Purchase Purchase of at least one goat per year Yes 142 42 
 No 199 58 
     
Tested before 2012 Farm tested for SRLV before the 2012 census 
(2006-2011) 
Yes 191 56 
 No 150 44 
 4 
Supplementary_Table_I
Supplementary Table II 1 
Characterization of continuous variables in a study to determine risk factors for SRLV 2 
seropositivity (n=341). 3 
Variable Mean Median Min Max 
     
Number of goats per farm     
Overall (n=341)* 32.2 14 1 300 
CAEV (n=32) 34.5 11 3 165 
VMV (n=100) 36.7 12.5 2 300 
SRLV (n=125) 35.4 12 2 300 
Controls (n=131) 30.0 13 1 270 
Number of bucks (n=341) 1.9 1 0 26 
Number of purchased goats / year (n=142)† 2.7 1.5 0 60 
Number of sheep (n=80)†† 32.6 11.5 2 600 
* including CAE positive by default tested farms 4 
† only for farms purchasing goats 5 
†† only for those farms where sheep were also present on the farm 6 
Supplementary_Table_II
Supplementary Table III 1 
Univariable analysis of variables tested for their association with VMV seropositivity in case (n=100) and control (n=131) herds. 2 
Variable Description 
Cases  Controls 
p value Odds Ratio 
Odds Ratio 
(95% CI) n %  n % 
    
 
     
Animal show 
Goats taken to breed shows or goat markets at least every other 
year 
30 30.0  41 31.3 0.832 0.94 0.53-1.66 
Breeding Breeding of animals done on farm 82 82.0  116 88.5 0.162 0.59 0.28-1.24 
Breed Appenzell Appenzell breed present in herd 7 7.0  3 2.3 0.097 3.21 0.81-12.75 
Breed dwarf goat Dwarf goat breed present in herd 18 18.0  17 13.0 0.293 1.47 0.72-3.03 
Contact alpine Common alpine pasture with foreign goats/sheep 34 34.0  37 28.2 0.348 1.31 0.75-2.30 
Contact sheep Keep goats and sheep together with direct contact 21 21.0  21 16.0 0.333 1.39 0.71-2.72 
Herd size 
  
  
 
 0.071 
  
 
Medium herd (7-40 goats) 39 39.0  71 54.2 (ref) 1.00 - 
 
Small herd (1-6 goats) 33 33.0  33 25.2 0.059 1.82 0.98-3.39 
 
Large herd (>40 goats) 28 28.0  27 20.6 0.058 1.89 0.98-3.64 
Know-how 
Know-how based on agricultural education and/or membership 
in a goat association 
78 78.0  114 87.0 0.072 0.53 0.26-1.06 
Own buck Breeding done with own buck(s) 55 55.0  87 66.4 0.078 0.62 0.36-1.06 
Purchase Purchase of at least one goat per year 36 36.0  59 45.0 0.167 0.69 0.40-1.17 
Purchase female Purchase of at least one female goat per year 18 18.0  20 15.3 0.579 1.22 0.61-2.45 
Tested before 2012 Farm tested for SRLV before the 2012 census (2006-2011) 63 63.0  72 55.0 0.219 1.40 0.82-2.38 
Wildlife 
  
  
 
 0.169 
  
 
No observed contact with wildlife 70 70.0  98 74.8 (ref) 1.00 - 
 
Observed contact with ibex 10 10.0  5 3.8 0.071 2.80 0.92-8.55 
 
Observed contact with chamois and other Swiss wildlife 20 20.0  28 21.4 1.000 1.00 0.52-1.92 
 3 
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